| 标题 |
LC-MS/MS method development and validation for novel targeted anticancer therapies adagrasib, capmatinib, ensartinib, entrectinib, larotrectinib, lorlatinib, pralsetinib, selpercatinib and sotorasib |
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal of Pharmaceutical and Biomedical Analysis 作者:Marinda Meertens; L. Daniëlle de Jong; Niels de Vries; Hilde Rosing; Jos H. Beijnen; Alwin D.R. Huitema 出版日期:2025-07-24 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)